CMH :: Clinical and Molecular Hepatology

Advances in the Combined Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

Advances in Clinical Medicine.2024; 14(01): 410. CrossRef

Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study

Luyun Yuan, Jinkai Feng, Yuqing Zhang, Chongde Lu, Liu Xu, Chao Liang, Zonghan Liu, Feifei Mao, Yanjun Xiang, Weijun Wang, Kang Wang, Shuqun Cheng

European Journal of Surgical Oncology.2023; 49(7): 1226. CrossRef

Diffusion-Weighted Imaging as a Quantitative Imaging Biomarker for Predicting Proliferation Rate in Hepatocellular Carcinoma: Developing a Radiomics Nomogram

Chuan Yan, Zewen Han, Xiaojie Chen, Lanmei Gao, Rongping Ye, Yueming Li

Journal of Computer Assisted Tomography.2023; 47(4): 539. CrossRef

Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm

Saneya Pandrowala, Shraddha Patkar, Mahesh Goel, Darius Mirza, S. K. Mathur

Langenbeck's Archives of Surgery.2023;[Epub] CrossRef

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Favorable Prognostic Factors for Survival Outcomes of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis After Hepatectomy

Sang-Hoon Kim, Deok-Bog Moon, Yo-Han Park, Sung-Gyu Lee, Ki-Hun Kim, Shin Hwang, Chul-Soo Ahn, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Minjae Kim, Byeong-Gon Na, Geunhyeok Yang, Sung Min Kim, Rak-kyun Oh

Annals of Surgical Oncology.2023; 30(7): 4279. CrossRef

Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?

Arvinder Soin, Mickaël Lesurtel, Prashant Bhangui, Lorenzo Cocchi, Mohamed Bouattour, Pierre-Alain Clavien

Journal of Hepatology.2023; 78(6): 1124. CrossRef

Treatment of hepatocellular carcinoma with macroscopic vascular invasion: A systematic review and network meta-analysis

Francisco Tustumi, Fabricio Ferreira Coelho, Daniel de Paiva Magalhães, Sérgio Silveira Júnior, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Luiz Augusto Carneiro D'Albuquerque, Paulo Herman

Transplantation Reviews.2023; 37(3): 100763. CrossRef

Preoperative MRI-based multiparametric model for survival prediction in hepatocellular carcinoma patients with portal vein tumor thrombus following hepatectomy

Lin Zhang, Tianying Zheng, Yuanan Wu, Hong Wei, Ting Yang, Xiaomei Zhu, Jie Yang, Yidi Chen, Yanshu Wang, Yali Qu, Jie Chen, Yun Zhang, Hanyu Jiang, Bin Song

European Journal of Radiology.2023; 165: 110895. CrossRef

Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study

Tingting Bai, Enxin Wang, Shoujie Zhao, Dandan Han, Yan Zhao, Hui Chen, Jun Zhu, Tenghui Han, Yang Bai, Yanju Lou, Yongchao Zhang, Man Yang, Luo Zuo, Jiahao Fan, Xing Chen, Jia Jia, Wenbin Wu, Weirong Ren, Yejing Zhu, Shouzheng Ma, Fenghua Xu, Yuxin Tang,

Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma

Zhenli Li, Mingda Zhao, Xingshun Qi, Yufu Tang, Shuqun Cheng

Journal of Cellular and Molecular Medicine.2023; 27(15): 2103. CrossRef

Endovascular brachytherapy with iodine-125 seed strand for extensive portal vein tumor thrombus in patients with hepatocellular carcinoma

Zhongbao Tan, Daguang Wu, Jinhe Guo, Huanjing Wang, Jian Zhang

Survival benefit of perioperative locoregional adjuvant treatment for hepatocellular carcinoma with portal vein tumor thrombosis: A systematic review and Bayesian network meta-analysis

Hao Sun, Bing Ma, Ning Sun, Han Bai, Xuejian Li, Chengshuo Zhang

Critical Reviews in Oncology/Hematology.2023; 189: 104083. CrossRef

Long-term outcomes of deceased donor liver transplantation in hepatocellular carcinoma patients with portal vein tumor thrombus: A multicenter study

Jiongjie Yu, Li Zhuang, Peng Liu, Zhikun Liu, Sunbin Ling, Yinan Deng, Jianhua Li, Bo Yang, Zhishui Chen, Zhengxin Wang, Yunjin Zang, Yang Yang, Shusen Zheng, Xiao Xu

European Journal of Surgical Oncology.2022; 48(1): 121. CrossRef

Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation

Qunfang Zhou, Yongcheng An, Ting Liu, Zishan Liu, Ruixia Li, Chenmeng Wang, Feng Zhou, Congjuan Liu, Kangshun Zhu

International Journal of Hyperthermia.2022; 39(1): 97. CrossRef

Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus

Annals of Hepatology.2022; 27(1): 100552. CrossRef

Efficacy and feasibility of surgery and external radiotherapy for hepatocellular carcinoma with portal invasion: A meta-analysis

Han Ah Lee, Yeon Seok Seo, In-Soo Shin, Won Sup Yoon, Hye Yoon Lee, Chai Hong Rim

International Journal of Surgery.2022; 104: 106753. CrossRef

An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma

Cheng He, Jing Yang, Zheng Jin, Ying Zhu, Wei Hu, Lingfeng Zeng, Xiaocheng Li, Qing Li

Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1. CrossRef

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical and Molecular Hepatology.2022; 28(4): 583. CrossRef

2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology.2022; 23(12): 1126. CrossRef

Potential Candidates for Liver Resection in Liver-Confined Advanced HCC: A Chinese Multicenter Observational Study

Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis

Emily L. Ryon, Joshua P. Kronenfeld, Rachel M. Lee, Adam Yopp, Annie Wang, Ann Y. Lee, Sommer Luu, Cary Hsu, Eric Silberfein, Maria C. Russell, Neha Goel, Nipun B. Merchant, Jashodeep Datta

Journal of Surgical Oncology.2021; 123(2): 407. CrossRef

Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II

Jia-Yu Lv, Ning-Ning Zhang, Ya-Wei Du, Ying Wu, Tian-Qiang Song, Ya-Min Zhang, Yan Qu, Yu-Xin Liu, Jie Gu, Ze-Yu Wang, Yi-Bo Qiu, Bing Yang, Da-Zhi Tian, Qing-Jun Guo, Li Zhang, Ji-San Sun, Yan Xie, Zheng-Lu Wang, Xin Sun, Wen-Tao Jiang, Wei Lu

Progress in the Treatment of Hepatocellular Carcinoma Complicated with Portal Vein Tumor Thrombus

Advances in Clinical Medicine.2021; 11(12): 6018. CrossRef

Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification

Masateru Yamamoto, Tsuyoshi Kobayashi, Masakazu Hashimoto, Shintaro Kuroda, Tomokazu Kawaoka, Hiroshi Aikata, Kazuaki Chayama, Hideki Ohdan

Efficacy and Safety of Transarterial Chemoembolization in Elderly Patients of Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Study

Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma

Duo Hong, Yi Zhou, Xiaoting Wan, Hongying Su, Haibo Shao

Could Photodynamic Therapy Be a Promising Therapeutic Modality in Hepatocellular Carcinoma Patients? A Critical Review of Experimental and Clinical Studies

Abhishek Kumar, Olivier Moralès, Serge Mordon, Nadira Delhem, Emmanuel Boleslawski

Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis

Jungang Hu, Quan Bao, Guang Cao, Xu Zhu, Renjie Yang, Xinqiang Ji, Liang Xu, Kanglian Zheng, Weiliang Li, Baocai Xing, Xiaodong Wang

CardioVascular and Interventional Radiology.2020; 43(7): 996. CrossRef

Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resection

Alessandra Bertacco, Alessandro Vitale, Claudia Mescoli, Umberto Cillo

Resection vs. Sorafenib for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Real World, Propensity Score Matched Analytic Study

Jie Mei, Shao-Hua Li, Qiao-Xuan Wang, Liang-He Lu, Yi-Hong Ling, Jing-Wen Zou, Wen-Ping Lin, Yu-Hua Wen, Wei Wei, Rong-Ping Guo

Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study

Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Eun Ju Cho, Seung Up Kim

Value of surgical resection compared to transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein tumor thrombus: A meta-analysis of hazard ratios from five observational studies

Keera Kang, Sung Kyu Song, Chul-Woon Chung, Yongkeun Park

Annals of Hepato-Biliary-Pancreatic Surgery.2020; 24(3): 243. CrossRef

The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis

Zhoujing Cheng, Lin He, Yingjie Guo, Yuhua Song, Shasha Song, Lijiu Zhang

World Journal of Surgical Oncology.2020;[Epub] CrossRef

Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis

Shun Kaneko, Kaoru Tsuchiya, Yutaka Yasui, Kento Inada, Sakura Kirino, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Takaya Takeguchi, Yuko Takeguchi, Takuya Nagano, Hiroyuki

Long-term Survival of a Patient with a Large Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis and Spontaneous Tumor Rupture

Hyung-Woo Lee, Gi-Ae Kim, Chi Hyuk Oh, Jae-Jun Shim, Byung-Ho Kim

Journal of Liver Cancer.2020; 20(2): 148. CrossRef

Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis

Jin‐Cheng Wang, An‐Liang Xia, Yong Xu, Xiao‐Jie Lu

Journal of Cellular Physiology.2019; 234(2): 1062. CrossRef

Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?

Aline Mähringer‐Kunz, Verena Steinle, Christoph Düber, Arndt Weinmann, Sandra Koch, Irene Schmidtmann, Sebastian Schotten, Jan B. Hinrichs, Dirk Graafen, Daniel Pinto dos Santos, Peter R. Galle, Roman Kloeckner

Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis

Xiu-Ping Zhang, Yan-Chen Liu, Zhen-Hua Chen, Ju-Xian Sun, Kang Wang, Zong-Tao Chai, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng

Annals of Surgical Oncology.2019; 26(5): 1465. CrossRef

Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus

Lei Huo, Wenxin Wei, Zhenlin Yan, Zhengqing Lei, Yanting Xie, Renyan Gong, Shengyu Huang, Ningyang Jia, Yong Xia

An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study

Xiu‐Ping Zhang, Yu‐Zhen Gao, Zhen‐Hua Chen, Min‐Shan Chen, Le‐Qun Li, Tian‐Fu Wen, Li Xu, Kang Wang, Zong‐Tao Chai, Wei‐Xing Guo, Jie Shi, Dong Xie, Meng‐Chao Wu, Wan Yee Lau, Shu‐Qun Cheng

Treatment Strategies for Hepatocellular Carcinoma – a Multidisciplinary Approach

Isabella Lurje, Zoltan Czigany, Jan Bednarsch, Christoph Roderburg, Peter Isfort, Ulf Peter Neumann, Georg Lurje

International Journal of Molecular Sciences.2019; 20(6): 1465. CrossRef

Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection

Mi Young Jeon, Hye Soo Kim, Tae Seop Lim, Dai Hoon Han, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Jin Sub Choi, Kwang-Hyub Han, Seung Up Kim, Gianfranco D. Alpini

2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

KLCA Korean Liver Cancer Association, NCC National Cancer Center

2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology.2019; 20(7): 1042. CrossRef

Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

Wenzhe Fan, Guosheng Yuan, Huishuang Fan, Fuliang Li, Yanqin Wu, Yue Zhao, Wang Yao, Yu Wang, Miao Xue, Jianyong Yang, Jiaping Li

Clinical Therapeutics.2019; 41(8): 1463. CrossRef

Texture analysis of multi-phase MRI images to detect expression of Ki67 in hepatocellular carcinoma

Y. Li, C. Yan, S. Weng, Z. Shi, H. Sun, J. Chen, X. Xu, R. Ye, J. Hong

Clinical Radiology.2019; 74(10): 813.e19. CrossRef

A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status

Hyo Jung Cho, Soon Sun Kim, So Young Kang, Min Jae Yang, Choong Kyun Noh, Jae Chul Hwang, Sun Gyo Lim, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Jin Hong Kim, Sung Won Cho, Jae Youn Cheong

Resection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis

Zun-Yi Zhang, Ke-Shuai Dong, Er-Lei Zhang, Li-Wei Zhang, Xiao-Ping Chen, Han-Hua Dong

The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review

G.K. Glantzounis, A. Paliouras, M.-C. Stylianidi, H. Milionis, P. Tzimas, D. Roukos, G. Pentheroudakis, E. Felekouras

European Journal of Surgical Oncology.2018; 44(2): 195. CrossRef

Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus

Biao Yang, Chun-Lin Li, Wen-hao Guo, Tian-qiang Qin, He Jiao, Ze-jun Fei, Xuan Zhou, Lin-jia Duan, Zheng-yin Liao

Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms

Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Juneyoung Lee, Hae Rim Kim, Yang Jae Yoo, Tae Suk Kim, Seong Hee Kang, Sang Jun Suh, Moon Kyung Joo, Young Kul Jung, Beom Jae Lee, Hyung Joon Yim, Jong Eun Yeon, Jae Seon Kim, Jong-Jae Park, Soon Ho Um, Young-Tae

Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein

Jin Hyoung Kim, Ju Hyun Shim, Hyun‐Ki Yoon, Heung‐Kyu Ko, Jong Woo Kim, Dong Il Gwon

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative

Kai Wang, Guomin Jiang, Zhongzhi Jia, Xiaoli Zhu, Caifang Ni

Hepatic resection compared to chemoembolization in intermediate‐ to advanced‐stage hepatocellular carcinoma: A meta‐analysis of high‐quality studies

Myung Han Hyun, Young‐Sun Lee, Ji Hoon Kim, Chan Uk Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun

A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus

Lei Liang, Ting-Hao Chen, Chao Li, Hao Xing, Jun Han, Ming-Da Wang, Han Zhang, Wan Yee Lau, Meng-Chao Wu, Feng Shen, Tian Yang

Comparison of three‐dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus

Fang Su, Kai‐Hua Chen, Zhong‐Guo Liang, Chun‐Hua Wu, Ling Li, Song Qu, Long Chen, Xiao‐Dong Zhu, Jian‐Hong Zhong, Le‐Qun Li, Bang‐De Xiang

Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis

Xinwei Yang, Zhiquan Qiu, Rongzhen Ran, Longjiu Cui, Xiangji Luo, Mengchao Wu, Wei‑Feng Tan, Xiaoqing Jiang

Effect of Korean Red Ginseng in chronic liver disease

Tae Young Park, Meegun Hong, Hotaik Sung, Sangyeol Kim, Ki Tae Suk

Journal of Ginseng Research.2017; 41(4): 450. CrossRef

Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection

Kenji Wakayama, Toshiya Kamiyama, Hideki Yokoo, Tatsuya Orimo, Shingo Shimada, Takahiro Einama, Hirofumi Kamachi, Akinobu Taketomi

Journal of Surgical Oncology.2017; 115(3): 324. CrossRef

Increased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis

Miao Liu, Lingyao Du, Zhiliang He, Libo Yan, Ying Shi, Jin Shang, Hong Tang

BioMed Research International.2017; 2017: 1. CrossRef

Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis

Charlotte E. Costentin, Thomas Decaens, Alexis Laurent, Jean‐Charles Nault, Bernard Paule, Christian Letoublon, Alain Luciani, Julien Calderaro, René Adam, Ivan Bricault, Giuliana Amaddeo, Daniel Cherqui, Ariane Mallat, Didier Samuel, Christophe Duvoux, N

Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation

Hye Won Lee, Hyun Soo Kim, Seung Up Kim, Do Young Kim, Beom Kyung Kim, Jun Yong Park, Sang Hoon Ahn, Mi Young Jeon, Ja Yoon Heo, Soo Young Park, Yu Rim Lee, Sun Kyung Jang, Su Hyun Lee, Se Young Jang, Won Young Tak, Kwang-Hyub Han

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

Xiu-Ping Zhang, Kang Wang, Nan Li, Cheng-Qian Zhong, Xu-Biao Wei, Yu-Qiang Cheng, Yu-Zhen Gao, Han Wang, Shu-Qun Cheng

Efficacy and safety of apatinib combined with transarterial chemoembolization for hepatocellular carcinoma with portal venous tumor thrombus: a retrospective study

Changfu Liu, Wenge Xing, Tongguo Si, Haipeng Yu, Zhi Guo

Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria

Yuri Cho, Jeong-Hoon Lee, Dong Hyeon Lee, Eun Ju Cho, Su Jong Yu, Nam-Joon Yi, Kwang-Woong Lee, Yoon Jun Kim, Jung-Hwan Yoon, Kyung-Suk Suh

Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study

Lin Zheng, Chen-Yang Guo, Cheng-Shi Chen, Jin-Cheng Xiao, Hong-Tao Hu, Hong-Tao Cheng, Deng-Wei Zong, Li Jiang, Hai-Liang Li

Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis

Young Youn Cho, Minjong Lee, Hyo-Cheol Kim, Jin Wook Chung, Yun Hwan Kim, Geum-Youn Gwak, Si Hyun Bae, Do Young Kim, Jeong Heo, Yoon Jun Kim, Matias A Avila

Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma

Michitoshi Takano, Takashi Kokudo, Yoshihiro Miyazaki, Yumiko Kageyama, Amane Takahashi, Katsumi Amikura, Hirohiko Sakamoto

World Journal of Gastroenterology.2016; 22(42): 9445. CrossRef